Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06159907
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2023-11-27
Brief Title:
Evaluation of the Diagnostic and Prognostic Role of PET PETCT and PETMRI in Gynecological Tumors
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Study Overview
Official Title:
Evaluation of the Diagnostic and Prognostic Role of PET PETCT and PETMRI in Gynecological Tumors
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Gynecological cancers involve several tumors of the female reproductive system The five most common gynecological tumors are those of the uterine cervix endometrium ovary vagina and vulva Furthermore although rarer there is a further gynecological tumor which is generated from the gestational trophoblast tissueThese pathologies represent an important burden for society since there are over nine hundred thousand cases in Europe
Ultrasound examination is the investigation commonly used to monitor high-risk women
Magnetic resonance imaging MRI is considered the most accurate imaging technique for presurgical staging of gynecological tumors Computed tomography CT on the other hand is not usually used for diagnosis but is considered very useful for investigating possible distant metastasesFinally integrated positron emission tomography PETCT and PETMRI methods are innovative molecular imaging techniques and represent a continually expanding field of research in the oncology setting including gynecological malignancies
The present study is of considerable clinical relevance as at our Institute it is possible to have a significant number of patients suffering from gynecological neoplastic pathologies that are studied using PET thus allowing the identification and validation of innovative imaging biomarkers with the use of both traditional imaging parameters and radiomic features
Ultrasound examination is the investigation commonly used to monitor high-risk women
Magnetic resonance imaging MRI is considered the most accurate imaging technique for presurgical staging of gynecological tumors Computed tomography CT on the other hand is not usually used for diagnosis but is considered very useful for investigating possible distant metastasesFinally integrated positron emission tomography PETCT and PETMRI methods are innovative molecular imaging techniques and represent a continually expanding field of research in the oncology setting including gynecological malignancies
The present study is of considerable clinical relevance as at our Institute it is possible to have a significant number of patients suffering from gynecological neoplastic pathologies that are studied using PET thus allowing the identification and validation of innovative imaging biomarkers with the use of both traditional imaging parameters and radiomic features
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None